CN101029056A - 聚-3-羟基丁酸酯在制备β-内酰胺化合物中的用途 - Google Patents

聚-3-羟基丁酸酯在制备β-内酰胺化合物中的用途 Download PDF

Info

Publication number
CN101029056A
CN101029056A CNA2006100132237A CN200610013223A CN101029056A CN 101029056 A CN101029056 A CN 101029056A CN A2006100132237 A CNA2006100132237 A CN A2006100132237A CN 200610013223 A CN200610013223 A CN 200610013223A CN 101029056 A CN101029056 A CN 101029056A
Authority
CN
China
Prior art keywords
described method
cooch
cho
tertiary butyl
obtains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2006100132237A
Other languages
English (en)
Other versions
CN101029056B (zh
Inventor
吕渭川
张谦
陈鑫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin GreenBio Materials Co., Ltd.
Original Assignee
TIANJIN GREEN BIOSCIENCES Ltd Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TIANJIN GREEN BIOSCIENCES Ltd Co filed Critical TIANJIN GREEN BIOSCIENCES Ltd Co
Priority to CN2006100132237A priority Critical patent/CN101029056B/zh
Priority to US12/280,781 priority patent/US7985857B2/en
Priority to KR1020087023768A priority patent/KR101071440B1/ko
Priority to JP2008556632A priority patent/JP5042243B2/ja
Priority to EP06804931A priority patent/EP1990334B1/en
Priority to PCT/CN2006/002707 priority patent/WO2007098651A1/zh
Publication of CN101029056A publication Critical patent/CN101029056A/zh
Application granted granted Critical
Publication of CN101029056B publication Critical patent/CN101029056B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/188Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开了聚-3-羟基丁酸酯P(3HB)在制备β-内酰胺化合物中的用途,本发明还公开了利用P(3HB)制备具有通式(I)的β-内酰胺化合物的方法,其中R为式(Ⅱ),R1、R2、R3为C1-C4的低级直链或支链烷基。利用本发明公开的方法,可以方便地制备通式(I)所述的化合物。该方法较之以前的方法步骤更短,收率更高,同时也更为避开了对环境污染的试剂及贵重试剂的使用,降低了成本并减少了环境污染。

Description

聚-3-羟基丁酸酯在制备β-内酰胺化合物中的用途
技术领域
本发明属于β-内酰胺化合物的生产领域,更具体地,本发明公开了聚3-羟基丁酸酯P(3HB)在制备具有通式(I)的β-内酰胺化合物中的应用:
Figure A20061001322300041
其中R为
Figure A20061001322300042
R1、R2、R3为C1-C4的低级直链或支链烷基。
背景技术
具有通式(I)的β-内酰胺化合物
Figure A20061001322300043
其中R为
Figure A20061001322300044
R1、R2、R3为C1-C4的低级直链或支链烷基是制备碳青霉烯类抗生素的重要中间体(Andrew H.Berks,“Tetrahydron”,第52卷,331页,1996年)。迄今为止,合成上述化合物的方法有很多,例如:由6-氨基青霉烷酸合成(Yoshida,A.;Hayashi,T.;Takeda,N.;Oida,S.;Ohki,E.Chem.Pharm.Bull.1981,29,2899-2909.);由苏氨酸合成(Shiozaki,M.;Ishida,N.;Maruyama,H.;Hiraoka,T.Tetrahedron 1983,39,2399-2407.);由(3R)-3-羟基丁酸甲酯合成(Ohashi,T.;Kan,K.;Ueyama,N.;Sada,I.;Miyama,A.;Watanabe,K.U.S.Patent US 4861877,Aug.29,1989.)等等,但这些方法或是在合成过程中使用了易造成污染的重金属化合物,如乙酸汞和四乙酸铅;或是使用了过多的硅试剂以及手性原料和催化剂,导致成本高昂。
因而寻找合适的起始原料,优化合成工艺从而减少成本高昂的试剂的使用或降低污染一直是本领域的技术人员着力解决的问题。
发明内容:
本发明的发明人通过大量实验,找到了制备如通式(I)的化合物
Figure A20061001322300051
的起始原料聚3-羟基丁酸P(3HB)并开发了适合大规模生产的合成上述化合物的工艺,即由P(3HB)得到取代的(3R)-3-羟基丁酸甲酯,还原后得到取代的(3R)-3-羟基丁醛,烯醇化后与氯磺酰异氰酸酯反应具有上述通式(I)的化合物,
其中R为
Figure A20061001322300052
R1、R2、R3为C1-C4的低级直链或支链烷基。该方法较之以前的方法步骤更短,收率更高,同时也避开了对环境污染的试剂及贵重试剂的使用,降低了成本并减少了环境污染。其反应路线如下:
Figure A20061001322300061
其中,R为
Figure A20061001322300062
R1、R2、R3为C1-C4的低级直链或支链烷基。
更具体地,本发明公开了:
1,P(3HB)在制备通式(I)化合物的用途:
Figure A20061001322300063
其中R为
Figure A20061001322300064
R1、R2、R3为C1-C4的低级直链或支链烷基。
2,上述1所述的用途,其中R为1-叔丁基二甲基硅基、异丙基二甲基硅基、三异丙基硅基之一。
3,一种利用P(3HB)制备上述通式(I)化合物的方法,包括:
a:P(3HB)裂解,保护得到(3R)-3-RO-CH(CH3)CH2COOCH3
b:(3R)-3-RO-CH(CH3)CH2COOCH3还原得到(3R)-3-RO-CH(CH3)CH2CHO;
c:(3R)-3-RO-CH(CH3)CH2CHO烯醇化后与氯磺酰异氰酸酯反应然后再还原得到终产品。
4,上述3所述的方法,其中步骤a为:P(3HB)与无水甲醇和硫酸回流经后处理得到初步产物,然后再和取代的甲硅烷氯进行反应。
5,上述4所述的方法,其中回流时间为三天。
6,上述3所述的方法,其中(3R)-3-RO-CH(CH3)CH2COOCH3为(3R)-3-叔丁基二甲基硅氧基丁酸甲酯。
7,上述3所述的方法,其中步骤c中烯醇化步骤为(3R)-3-RO-CH(CH3)CH2CHO和乙酸异丙烯酯、对甲苯磺酸混合加热回流进行反应。
8,上述3所述的方法,其中步骤c中使用的还原剂为亚硫酸氢钠。
本发明中使用的起始原料聚3-羟基丁酸酯P(3HB)是一种热塑性树酯,有良好的生物分解性和生物适应性,主要作为生物降解材料使用。本发明利用其作为合成具有通式(I)的β-内酰胺化合物的起始原料,可以方便地得到3-羟基被RO取代的(3R)-3-RO-CH(CH3)CH2COOCH3,与利用(3R)-3-羟基丁酸甲酯合成的取代的(3R)-3-RO-CH(CH3)CH2COOCH3相比,具有价格低廉的优点。更进一步,其反应条件为P(3HB)与甲醇、硫酸回流经后处理得到初步产物,然后再和取代的甲硅烷氯进行反应得到(3R)-3-RO-CH(CH3)CH2COOCH3
利用P(3HB)得到的(3R)-3-RO-CH(CH3)CH2COOCH3可以在常规的反应条件下得到(3R)-3-RO-CH(CH3)CH2CHO,例如在低温下利用二异丁基氢铝进行反应后加入酒石酸钾钠饱和溶液当中,再加入乙醚经萃取、干燥、蒸干然后过硅胶柱即可。
(3R)-3-RO-CH(CH3)CH2CHO经过烯醇化得到稳定的烯醇化物以后和氯磺酰异氰酸酯反应后得到的产物利用温和的还原剂亚硫酸氢钠进行还原再经硅胶柱纯化后可得ee值99%以上的终产品。
具体实施方式:
以下实施例仅对本发明进行进一步的说明,不应理解为对本发明的任何限制。本发明中如果没有特别说明,产率均为摩尔收率,试剂如果没有言明,均为市售化学纯试剂。
P(3HB)天津国韵生物科技有限公司产品
旋光仪型号:WZZ-1     上海精密仪器仪表有限公司
核磁共振仪型号:Bruker AVANCE DRX-500     布鲁克光谱仪器公司
熔点仪型号:WRS-2A    上海精密仪器仪表有限公司
实施例1:(3R)-3-叔丁基二甲基硅氧基丁酸甲酯的制备
将80克P(3HB)溶于1升无水二氯乙烷中,回流一个小时后,加入20毫升浓硫酸以及400毫升无水甲醇,再回流三天后冷却至室温,向反应混合物中投入200毫升饱和食盐水,搅拌30分钟后,分出水相,并用500毫升氯仿分三次洗涤水相,合并有机相并分别用200毫升饱和食盐水,200毫升饱和碳酸氢钠溶液,200毫升饱和食盐水分三次洗涤有机相。有机相用硫酸镁干燥,减压蒸除溶剂后,残留物减压蒸馏,收集61-62摄氏度/18毫米汞柱馏分,得产物104克,将以上产物投入三口瓶中,加入400毫升二氯甲烷,50克咪唑,搅拌均匀后缓慢加入3-叔丁基二甲基甲硅烷氯120克,反应5小时后过滤,将滤液分别用饱和碳酸氢钠,盐酸以及饱和食盐水洗涤,分出有机相无水硫酸镁干燥过夜,减压浓缩后得到(3R)-3-叔丁基二甲基硅氧基丁酸甲酯200克,产率92.5%。
实施例2(3R)-三异丙基硅氧基丁酸甲酯的制备
同实施例1,只是用三异丙基甲硅烷氯替代3-叔丁基二甲基甲硅烷氯,得到(3R)-三异丙基硅氧基丁酸甲酯223克,产率87.2%。
实施例3(3R)-3-叔丁基二甲基硅氧基丁醛的制备
(3R)-3-叔丁基二甲基硅氧基丁酸甲酯46.4克,溶于200毫升正己烷中,冷却至-78摄氏度,缓缓滴入240毫升1mol/L的二异丁基氢铝的正己烷溶液,加完之后,在此温度下继续反应2个小时,反应完成后,缓慢升温,将反应液倒入1升的酒石酸钾钠饱和溶液当中,再加入乙醚1.5升,水0.5升激烈搅拌1个小时,分液,有机相用饱和食盐水洗,水相分三次用1.2升乙醚萃取,合并有机相,硫酸钠干燥过夜,减压蒸除溶剂,粗品经硅胶柱色谱纯化(洗脱液的配比:乙酸乙酯∶己烷=1∶1)得(3R)-3-叔丁基二甲基硅氧基丁醛39.7克,产率98.3%。
实施例4(3R)-三异丙基硅氧基丁醛的制备
同实施例3,只是将(3R)-3-叔丁基二甲基硅氧基丁酸甲酯改为(3R)三异丙基硅氧基丁酸甲酯,投料量为54.8克得到(3R)-三异丙基硅氧基丁醛44克,产率90.2%
实施例5(3R,4R)-4-乙酰氧基-3-[(R)-1-叔丁基二甲基甲硅烷氧基乙基]-氮杂环丁-2-酮的制备
将20.2克(3R)-3-叔丁基二甲基硅氧基丁醛,15克乙酸异丙烯酯,1克对甲苯磺酸混合加热回流,上置韦氏精馏柱,将体系中生成的丙酮蒸馏干净以后,残液用饱和碳酸氢钠溶液调至中性,减压蒸除水和原料的共沸混合物后,得烯醇化产物17.2克,产率70.5%。
取上述粗产品4.90克溶于25毫升二氯甲烷,冰水冷却到0摄氏度,将氯磺酰异氰酸酯3.40克缓慢加入,使体系温度低于0摄氏度,反应两个小时后,得红棕色反应混合物,随即将其冷却到-40摄氏度,将冷却后的溶液慢慢滴入激烈搅拌的200毫升0摄氏度的饱和亚硫酸钠溶液中,用饱和氢氧化钠溶液调溶液pH值8-10,薄层色谱监控反应进程,待原料反应完全后,分出有机相,硫酸镁干燥过夜,减压蒸除溶剂后,硅胶柱色谱纯化(洗脱液的配比:乙酸乙酯∶己烷=1∶10)得到(3R,4R)-4-乙酰氧基-3-[(R)-1-叔丁基二甲基甲硅烷氧基乙基]-氮杂环丁-2-酮,正己烷中重结晶,得白色针状晶体3.40克,产率59.0%。此白色针状晶体即为最终产物,本路线共计三步,总产率37.8%。
产品旋光度:53-57°(c=0.5,CHCl3)
核磁共振谱(500MHz,CDCl3)
δ(ppm):0.08(6H,s),0.84(9H,s),1.20(3H,d),2.01(3H,s),3.04(1H,dd),4.12(1H,m),5.76(1H,d),6.73(NH)
熔点:106-110℃
实施例6(3R,4R)-4-乙酰氧基-3-[(R)-三异丙基硅烷氧基乙基]-氮杂环丁-2-酮的制备
同实施例5,只是将(3R)-3-叔丁基二甲基硅氧基丁醛改为(3R)-三异丙基硅氧基丁醛,投料量为24.4克得到终产品10.9克,总产率33.1%。
本发明得到的终产品的熔点、旋光度以及核磁数据和中国发明专利申请号85105097公开的产品的数据一致。

Claims (8)

1.P(3HB)在制备通式(I)化合物的用途:
Figure A2006100132230002C1
(I)
其中R为
Figure A2006100132230002C2
,R1、R2、R3为C1-C4的低级直链或支链烷基。
2.权利要求1所述的用途,其中R为1-叔丁基二甲基硅基、异丙基二甲基硅基、三异丙基硅基之一。
3.一种利用P(3HB)制备上述通式(I)化合物的方法,包括:
a.将P(3HB)裂解,保护得到(3R)-3-RO-CH(CH3)CH2COOCH3
b.将(3R)-3-RO-CH(CH3)CH2COOCH3还原得到(3R)-3-RO-CH(CH3)CH2CHO;
c.将(3R)-3-RO-CH(CH3)CH2CHO烯醇化后与氯磺酰异氰酸酯反应然后再还原得到终产品。
4.权利要求3所述的方法,其中步骤a为P(3HB)与无水甲醇和硫酸回流经后处理得到初步产物,然后再和取代的甲硅烷氯进行反应。
5.权利要求4所述的方法,其中回流时间为三天。
6.权利要求3所述的方法,其中(3R)-3-RO-CH(CH3)CH2COOCH3为(3R)-3-叔丁基二甲基硅氧基丁酸甲酯。
7.权利要求3所述的方法,其中步骤c中烯醇化步骤为(3R)-3-RO-CH(CH3)CH2CHO和乙酸异丙烯酯、对甲苯磺酸混合在加热回流的条件下进行。
8.权利要求3所述的方法,其中步骤c中使用的还原剂为亚硫酸氢钠。
CN2006100132237A 2006-02-28 2006-02-28 聚-3-羟基丁酸酯在制备β-内酰胺化合物中的用途 Expired - Fee Related CN101029056B (zh)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CN2006100132237A CN101029056B (zh) 2006-02-28 2006-02-28 聚-3-羟基丁酸酯在制备β-内酰胺化合物中的用途
US12/280,781 US7985857B2 (en) 2006-02-28 2006-10-16 Usage of poly-3-hydroxybutyrates in preparation of β-lactam compounds
KR1020087023768A KR101071440B1 (ko) 2006-02-28 2006-10-16 β-락탐 화합물의 제조에서의 폴리-3-히드록시부티레이트의용도
JP2008556632A JP5042243B2 (ja) 2006-02-28 2006-10-16 ポリ−3−ヒドロキシブチレートを用いてβ−ラクタム化合物を調製する方法
EP06804931A EP1990334B1 (en) 2006-02-28 2006-10-16 Usage of poly-3-hydroxyalkanoates in preparation of beta-lactam compounds
PCT/CN2006/002707 WO2007098651A1 (fr) 2006-02-28 2006-10-16 UTILISATION DE POLY-3-HYDROXYALCANOATES POUR LA PRÉPARATION DE COMPOSÉS DE β-LACTAME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2006100132237A CN101029056B (zh) 2006-02-28 2006-02-28 聚-3-羟基丁酸酯在制备β-内酰胺化合物中的用途

Publications (2)

Publication Number Publication Date
CN101029056A true CN101029056A (zh) 2007-09-05
CN101029056B CN101029056B (zh) 2011-06-08

Family

ID=38458644

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006100132237A Expired - Fee Related CN101029056B (zh) 2006-02-28 2006-02-28 聚-3-羟基丁酸酯在制备β-内酰胺化合物中的用途

Country Status (6)

Country Link
US (1) US7985857B2 (zh)
EP (1) EP1990334B1 (zh)
JP (1) JP5042243B2 (zh)
KR (1) KR101071440B1 (zh)
CN (1) CN101029056B (zh)
WO (1) WO2007098651A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115850065A (zh) * 2022-10-14 2023-03-28 东莞理工学院 一种以硫酸氢钠为催化剂催化聚3-羟基丁酸酯降解制备r-3-羟基丁酸酯的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003960B1 (de) * 1978-02-02 1983-06-29 Ciba-Geigy Ag 6-Substituierte Thia-Azaverbindungen, ihre Herstellung und diese enthaltende pharmazeutische Präparate
US4680391A (en) * 1983-12-01 1987-07-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US4791198A (en) * 1984-07-05 1988-12-13 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Beta-lactam compound and preparation thereof
JPS6118791A (ja) * 1984-07-05 1986-01-27 Kanegafuchi Chem Ind Co Ltd 新規β−ラクタム化合物及びその製造法
US4861877A (en) 1984-07-05 1989-08-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives
JPS6118758A (ja) * 1985-01-14 1986-01-27 Kanegafuchi Chem Ind Co Ltd 4−アセトキシ−ヒドロキシエチルアゼチジン−2−オン誘導体の製造法
EP0259268A1 (de) * 1986-09-04 1988-03-09 Ciba-Geigy Ag Verfahren zur Herstellung optisch aktiver Beta-Lactame

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115850065A (zh) * 2022-10-14 2023-03-28 东莞理工学院 一种以硫酸氢钠为催化剂催化聚3-羟基丁酸酯降解制备r-3-羟基丁酸酯的方法

Also Published As

Publication number Publication date
JP2009528300A (ja) 2009-08-06
US20090088566A1 (en) 2009-04-02
US7985857B2 (en) 2011-07-26
KR101071440B1 (ko) 2011-10-10
JP5042243B2 (ja) 2012-10-03
EP1990334B1 (en) 2013-03-06
KR20080098444A (ko) 2008-11-07
EP1990334A1 (en) 2008-11-12
EP1990334A4 (en) 2011-02-23
WO2007098651A1 (fr) 2007-09-07
CN101029056B (zh) 2011-06-08

Similar Documents

Publication Publication Date Title
CN103965089B (zh) 一种立体选择性的合成降血脂药物依折麦布的方法
EA022032B1 (ru) Способ получения глюкопиранозилзамещенных производных бензилбензола
EP3148979B1 (en) Process for preparation of canagliflozin
JP2015528434A (ja) トリフルオロメチル含有直鎖炭酸エステルの製造方法
CN112358427B (zh) 一种三氟甲硫酯类化合物的合成方法
CN101029056B (zh) 聚-3-羟基丁酸酯在制备β-内酰胺化合物中的用途
CN1696096A (zh) 艾地苯醌的合成方法
EP3166918B1 (en) Metal-catalyzed asymmetric 1,4-conjugate addition of vinylboron compounds to 2-substituted-4-oxy- cyclopent-2-en-1-ones yielding prostaglandins and prostaglandin analogs
CN113045416B (zh) 一种(r)-3-羟基丁酰-(r)-3-羟基丁酯的制备方法
CN100348588C (zh) 一种嘧啶硫酮的化学合成方法
CN1765908A (zh) 二硬酯基季戊四醇二亚磷酸酯的合成新方法
CN108017658B (zh) 一种头孢丙烯的合成方法
CN1835918A (zh) 外消旋2-{[2-(4-羟基苯基)乙基]硫基}-3-[4-(2-{4-[(甲磺酰基)氧基]苯氧基}乙基)苯基]-丙酸的制备方法
CN111533656A (zh) 一种4-甲氧基-3-氧代丁酸叔丁酯的合成方法
CN1939924A (zh) 一种工业化生产法罗培南钠的方法
US6207841B1 (en) Bisphenol derivative and its manufacturing method
CN112521278B (zh) 一种制备羧酸酯化合物的方法
CN113461585B (zh) 格隆溴铵的合成工艺
CN1300117C (zh) 微波辐射合成1,3-二取代咪唑-2-硫酮的方法
JP3773578B2 (ja) タキソール合成中間体
CN101891665B (zh) (3s,4s)-4-乙酰基-3-((r)-1-羟基乙基)-2-氮杂环丁酮及其制备方法
JP5623099B2 (ja) N−オキシカルボニル−(2s)−オキシカルボニル−(5s)−ホスホニルピロリジン誘導体の製造方法
JP2933651B2 (ja) 4―アシロキシ―2―アゼチジノン誘導体の製造法
CN116462622A (zh) 一种N-Boc-L-脯氨醛的制备方法
CN115448858A (zh) 一种2-氯乙基磺酸钠的高效合成工艺

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: TIANJIN GREEN BIOMATERIAL CO., LTD.

Free format text: FORMER OWNER: TIANJIN GREEN BIOSCIENCES LIMITED COMPANY

Effective date: 20110331

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 300457 TIANJIN UNIVERSITY SCIENCE AND TECHNOLOGY PARK, B7, NO. 80, THE 4TH STREET, TAIDA ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE, TIANJIN CITY TO: 300462 NO. 128, XINXING ROAD, WEST AREA OF TIANJIN ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE

TA01 Transfer of patent application right

Effective date of registration: 20110331

Address after: 300462, No. 128, Xinxing Road, west end, Tianjin economic and Technological Development Zone

Applicant after: Tianjin GreenBio Materials Co., Ltd.

Address before: 300457, Tianjin TEDA economic and Technological Development Zone, No. fourth, 80 Avenue, B7 great science park

Applicant before: Tianjin Green Biosciences Limited Company

C14 Grant of patent or utility model
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Use of poly-3-ester oxybate in preparation of beta-lactam compound

Effective date of registration: 20140507

Granted publication date: 20110608

Pledgee: Zhongxing United Investment Company Limited

Pledgor: Tianjin GreenBio Materials Co., Ltd.

Registration number: 2014990000333

PLDC Enforcement, change and cancellation of contracts on pledge of patent right or utility model
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20140708

Granted publication date: 20110608

Pledgee: Zhongxing United Investment Company Limited

Pledgor: Tianjin GreenBio Materials Co., Ltd.

Registration number: 2014990000333

PLDC Enforcement, change and cancellation of contracts on pledge of patent right or utility model
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Use of poly-3-ester oxybate in preparation of beta-lactam compound

Effective date of registration: 20140715

Granted publication date: 20110608

Pledgee: Beijing Zhonglian new material investment management center (limited partnership)

Pledgor: Tianjin Green Biosciences Limited Company

Registration number: 2014990000573

PLDC Enforcement, change and cancellation of contracts on pledge of patent right or utility model
DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Jin Ming

Document name: Notice of termination of patent

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110608

Termination date: 20200228